Rocket Pharmaceuticals (RCKT) Prepaid Assets (2014 - 2026)
Rocket Pharmaceuticals (RCKT) reported Prepaid Assets of $5.4 million for Q1 2026, down 13.92% on a YoY basis from $6.3 million in Q1 2025, and up 43.18% sequentially from $3.8 million in Q4 2025.
Rocket Pharmaceuticals (RCKT) Prepaid Assets (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 13 years of Prepaid Assets data on file, last reported at $5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 13.92% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (down 13.92% YoY), and the FY2025 full-year result was $3.8 million, down 34.92% from the prior year.
- Prepaid Assets improved to $5.4 million in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $14.8 million in Q1 2024 to a low of $3.8 million in Q4 2025.
- A 5-year average of $6.9 million and a median of $5.8 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 176.12% in 2024 and sank 59.27% in 2025, its largest moves.
- Tracing RCKT's Prepaid Assets over 5 years: stood at $7.7 million in 2022, then slumped by 34.16% to $5.0 million in 2023, then gained by 15.85% to $5.8 million in 2024, then sank by 34.92% to $3.8 million in 2025, then soared by 43.18% to $5.4 million in 2026.
- Business Quant data shows RCKT's Prepaid Assets at $5.4 million in Q1 2026, $3.8 million in Q4 2025, and $4.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rocket Pharmaceuticals | 357.93 Mn | 357.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.45 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | 6.33 Mn |
| Dec 31, 2024 | 5.85 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Jun 30, 2024 | 13.90 Mn |
| Mar 31, 2024 | 14.85 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | 9.69 Mn |
| Jun 30, 2023 | 5.03 Mn |
| Mar 31, 2023 | 6.95 Mn |
| Dec 31, 2022 | 7.67 Mn |
| Sep 30, 2022 | 4.60 Mn |
| Jun 30, 2022 | 4.40 Mn |
| Mar 31, 2022 | 7.26 Mn |
| Dec 31, 2021 | 3.32 Mn |
| Sep 30, 2021 | 3.61 Mn |
| Jun 30, 2021 | 3.60 Mn |